Search News Archives
VIEW THE LATEST ISSUE
Microscopy | Image Analysis
IT Solutions and Laboratory Automation
Conferences | Events
Telstar doubles the production of Boreas -86º ultra-low temperature freezers
To meet the demand required by the new production and distribution of Covid-19 vaccines
Telstar has reinforced the production of Boreas, a -86º ultra-low-temperature freezers, to meet the growing demand in the short term generated by the industrial production of new vaccines to treat Covid-19.
The company will double the manufacturing of the latest generation of ultra-low-temperature freezers that complies with all the stringent requirements of storage needed to protect the integrity of vaccines not only in hospitals but also in logistic and transport processes.
Boreas has been designed to increase average performance by 20%. An innovative mechanical design enhances robustness, efficiency and ergonomics as well as ensuring the integrity of the cold preservation process. Equipped VIP with vacuum panels, the freezer guarantees the highest level of thermal insulation and maintains a temperature of -80ºC with ambient temperatures up to +28ºC. Unlike standard freezers designed with panels based on polyurethane foam, a thinner inner insulation provides Boreas with an enlarged storage capacity of up to 30%. Boreas uses high purity natural refrigerant CFC free gases that contribute to environment preservation. The ecological ultra-low-freezers line has been developed using Telstar’s in-house cold storage technology.
Telstar is a leading global brand of aseptic process solutions. The company is specialized in the development of process equipment & integrated solutions in isolation technology systems, sterilization and freeze-drying applications covering all the critical phases of the injectable vaccine production according to the higher requirements of quality to remove risks in manufacturing processes. To face the next medium-term phase, Telstar has also strengthened the development of the cutting-edge freeze-drying systems for the manufacturing of Covid-19 vaccines under lyophilized form to guarantee its complete distribution to across the globe, while the conservation and integrity are totally ensured.